Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
1 |
2 |
? - ? |
Vancomycin (Vancocyn, Lyphocin) |
39 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
1 |
3 |
? - ? |
Cefepime (Maxipime) |
126 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
≤2 |
≤2 |
≤2 - ? |
Gentamicin (Gentamycin, Garamycin) |
265 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
2 |
2 |
? - ? |
Vancomycin (Vancocyn, Lyphocin) |
126 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
2 |
4 |
≤0.25 - >32 |
Ceftriaxone (Rocephin) |
412 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
2 |
12 |
? - ? |
Ceftriaxone (Rocephin) |
126 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
4 |
8 |
0.25 - >16 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
412 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
>4 |
>8 |
? - ? |
Tetracycline (Sumycin, Achromycin V, Steclin) |
39 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
8 |
12 |
? - ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
126 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
8 |
12 |
? - ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
126 |
Staphylococci (coagulase-negative + oxacillin-susceptible) |
- |
4 |
8 - ? |
Chloramphenicol (Chloromycetin) |
39 |